Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Fischer

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Nature Chemical Biology|July 29, 2024
Template-assisted covalent modification underlies activity of covalent molecular gluesYen-Der Li, Michelle W Ma, Muhammad Murtaza Hassan, et al.
Molecular Cell|July 21, 2023
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stabilityJonathan M Tsai, Jacob D Aguirre, Yen-Der Li, et al.
Nature Chemical Biology|February 16, 2026
High-throughput ligand diversification to discover chemical inducers of proximityJames B Shaum, Miquel Muñoz I Ordoño, Erica A Steen, et al.
Science Translational Medicine|September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependenceGongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Cell|March 21, 2026
The E3-ome gene-centric compendium reveals the human E3 ligase landscapeNgee Kiat Chua, Tania J González-Robles, Cameron J Reddington, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Nature Chemical Biology|July 29, 2024
Template-assisted covalent modification underlies activity of covalent molecular gluesYen-Der Li, Michelle W Ma, Muhammad Murtaza Hassan, et al.
Molecular Cell|July 21, 2023
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stabilityJonathan M Tsai, Jacob D Aguirre, Yen-Der Li, et al.
Nature Chemical Biology|February 16, 2026
High-throughput ligand diversification to discover chemical inducers of proximityJames B Shaum, Miquel Muñoz I Ordoño, Erica A Steen, et al.
Science Translational Medicine|September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependenceGongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Cell|March 21, 2026
The E3-ome gene-centric compendium reveals the human E3 ligase landscapeNgee Kiat Chua, Tania J González-Robles, Cameron J Reddington, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 16